Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 8 | $19,186,399 |
| Sells | 7 | $465,624 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 01 Jul 2024 08:00 | TSHA | Taysha Gene Therapies Inc | MANNING PAUL B | 10% | 27 Jun 2024 | Purchase | 1,333,333 | 2.25 | 2,999,999 | D |
| 20 Nov 2023 07:35 | TSHA | Taysha Gene Therapies Inc | MANNING PAUL B | 10% | 17 Nov 2023 | Purchase | 100,000 | 1.63 | 163,000 | I |
| 25 Aug 2023 16:30 | TSHA | Taysha Gene Therapies Inc | ALAM KAMRAN | Chief Financial Officer | 24 Aug 2023 | Sale | 33,000 | 2.33 | 76,890 | D |
| 16 Aug 2023 20:57 | TSHA | Taysha Gene Therapies Inc | MANNING PAUL B | 10% | 16 Aug 2023 | Purchase | 16,466,667 | 0.9 | 14,820,000 | I |
| 16 Aug 2023 20:53 | TSHA | Taysha Gene Therapies Inc | STALFORT JOHN A III | Director | 16 Aug 2023 | Purchase | 388,889 | 0.9 | 350,000 | D |
| 16 Aug 2023 20:53 | TSHA | Taysha Gene Therapies Inc | STALFORT JOHN A III | Director | 16 Aug 2023 | Purchase | 388,889 | 0.9 | 350,000 | I |
| 16 Aug 2023 20:52 | TSHA | Taysha Gene Therapies Inc | NOLAN SEAN P. | Chief Executive Officer | 16 Aug 2023 | Purchase | 444,444 | 0.9 | 400,000 | I |
| 16 Aug 2023 20:51 | TSHA | Taysha Gene Therapies Inc | DONENBERG PHILLIP B. | Director | 16 Aug 2023 | Purchase | 111,111 | 0.9 | 100,000 | D |
| 14 Jul 2023 16:00 | TSHA | Taysha Gene Therapies Inc | SESSION R.A. II | 10% | 13 Jul 2023 | Sale | 5,344 | 0.7 | 3,741 | D |
| 14 Jul 2023 16:00 | TSHA | Taysha Gene Therapies Inc | SESSION R.A. II | 10% | 12 Jul 2023 | Sale | 80,528 | 0.7082 | 57,030 | D |
| 26 Jun 2023 16:46 | TSHA | Taysha Gene Therapies Inc | SESSION R.A. II | 10% | 23 Jun 2023 | Sale | 18,100 | 0.7036 | 12,735 | D |
| 26 Jun 2023 16:46 | TSHA | Taysha Gene Therapies Inc | SESSION R.A. II | 10% | 22 Jun 2023 | Sale | 10,508 | 0.7027 | 7,384 | D |
| 22 Jun 2023 16:00 | TSHA | Taysha Gene Therapies Inc | SESSION R.A. II | 10% | 21 Jun 2023 | Sale | 138,962 | 0.7026 | 97,635 | D |
| 22 Jun 2023 16:00 | TSHA | Taysha Gene Therapies Inc | SESSION R.A. II | 10% | 20 Jun 2023 | Sale | 295,653 | 0.711 | 210,209 | D |
| 18 May 2023 16:44 | TSHA | Taysha Gene Therapies Inc | NAGENDRAN SUKUMAR | President and Head of R&D | 16 May 2023 | Purchase | 5,000 | 0.68 | 3,400 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)